Viewing Study NCT06668961


Ignite Creation Date: 2025-12-24 @ 12:17 PM
Ignite Modification Date: 2026-01-02 @ 2:44 PM
Study NCT ID: NCT06668961
Status: RECRUITING
Last Update Posted: 2025-01-20
First Post: 2024-10-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of SI-B001+SI-B003 Combined With Platinum-based Chemotherapy as First-line Treatment in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-11-07
Start Date Type: ACTUAL
Primary Completion Date: 2026-11
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-11
Completion Date Type: ESTIMATED
First Submit Date: 2024-10-30
First Submit QC Date: None
Study First Post Date: 2024-11-01
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-01-16
Last Update Post Date: 2025-01-20
Last Update Post Date Type: ACTUAL